Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients

BACKGROUND: Shortening tuberculosis (TB) treatment duration is a research priority. This paper presents data from a prematurely terminated randomized clinical trial, of 4-month moxifloxacin or gatifloxacin regimens, in South India. METHODS: Newly diagnosed, sputum-positive HIV-negative pulmonary TB...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jawahar, Mohideen S., Banurekha, Vaithilingam V., Paramasivan, Chinnampedu N., Rahman, Fathima, Ramachandran, Rajeswari, Venkatesan, Perumal, Balasubramanian, Rani, Selvakumar, Nagamiah, Ponnuraja, Chinnaiyan, Iliayas, Allaudeen S., Gangadevi, Navaneethapandian P., Raman, Balambal, Baskaran, Dhanaraj, Kumar, Santhanakrishnan R., Kumar, Marimuthu M., Mohan, Victor, Ganapathy, Sudha, Kumar, Vanaja, Shanmugam, Geetha, Charles, Niruparani, Sakthivel, Murugesan R., Jagannath, Kannivelu, Chandrasekar, Chockalingam, Parthasarathy, Ramavaram T., Narayanan, Paranji R.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3700922/
https://ncbi.nlm.nih.gov/pubmed/23843980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0067030
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars